Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:2600-2603
doi: 10.1161/01.STR.0000035285.43467.FF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zunker, P.
Right arrow Articles by Deuschl, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zunker, P.
Right arrow Articles by Deuschl, G.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Angiography
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Doppler ultrasound, Transcranial Doppler etc.

(Stroke. 2002;33:2600.)
© 2002 American Heart Association, Inc.


Original Contributions

Echo Contrast–Enhanced Transcranial Ultrasound

Frequency of Use, Diagnostic Benefit, and Validity of Results Compared With MRA

Peter Zunker, PhD, MD; Henrik Wilms, MD; Joachim Brossmann, MD; Dimitrios Georgiadis, MD; Sepp Weber, MD Günther Deuschl, MD

From the Department of Neurology (P.Z., H.W., G.D.) and Institute of Radiology (J.B.), Kiel University Hospital, Kiel; Department of Neurology, Heidelberg University Hospital, Heidelberg (D.G.); and Schering Deutschland GmbH, Berlin (S.W.), Germany.

Correspondence to Peter Zunker, PhD, MD, Ita-Wegman-Hospital, 4144 Arlesheim, Switzerland. E-mail peter.zunker{at}wegmanklinik.ch

Background and Purpose— The present study was undertaken to determine the frequency of use of the ultrasound contrast agent (UCA) Levovist in routine transcranial ultrasound (TU). Additionally, we evaluated the diagnostic validity of contrast-enhanced TU using 3-dimensional time of flight MR angiography.

Methods— Indication for the UCA was an insufficient evaluation of the intracranial arteries after a combined approach with transcranial color-coded Duplex and transcranial Doppler examination. We prospectively analyzed every patient referred for TU over 6 months. Additionally, over a 3-month period, TU results were compared with 3-dimensional time-of-flight MR angiography .

Results— Indication for use of UCA was met in 61 of 687 patients (8.8%). After UCA application, a diagnostic result was achieved in 75% of cases during transtemporal and in 81% during transforaminal insonation. The sensitivity and specificity of TU in the diagnosis of intracranial stenosis were 83% and 82%, respectively.

Conclusions— Use of UCA was necessary in 8.8% of the patients. A diagnostic benefit was achieved in 75% to 80% of cases. Contrast-enhanced TU demonstrated a high sensitivity and specificity in the diagnosis of intracranial stenosis.


Key Words: cerebral arteries • contrast media • ultrasonics




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
A. Kunz, G. Hahn, D. Mucha, A. Muller, K.M. Barrett, R. von Kummer, and G. Gahn
Echo-Enhanced Transcranial Color-Coded Duplex Sonography in the Diagnosis of Cerebrovascular Events: A Validation Study
AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2122 - 2127.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. A. Sloan, A. V. Alexandrov, C. H. Tegeler, M. P. Spencer, L. R. Caplan, E. Feldmann, L. R. Wechsler, D. W. Newell, C. R. Gomez, V. L. Babikian, et al.
Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology, May 11, 2004; 62(9): 1468 - 1481.
[Abstract] [Full Text] [PDF]